Charcot-Marie-Tooth Disease Axonal Type 2S (CMT2S)

Other names
Types
Causes
Symptoms
Diagnostic tests
Non-pharmacological treatments
Drug treatments
Dietary molecular supplements
Immune-booster / regenerative / stem-cell-related drugs
Surgeries
Prevention and lifestyle
What to eat and what to avoid
When to see a doctor
FAQs

Charcot-Marie-Tooth disease axonal type 2S (CMT2S) is a rare, inherited nerve disease that mainly damages the long “wires” (axons) of the peripheral nerves. These are the nerves that connect the spinal cord to the muscles and to the skin for feeling. In CMT2S, the axon slowly becomes sick and dies back, especially in the nerves to the feet and hands. NCBI+1

Charcot-Marie-Tooth disease axonal type 2S (CMT2S) is a rare inherited nerve disease. It mainly damages the long “wires” (axons) of the peripheral nerves that carry signals to and from the hands and feet. People usually develop symptoms in childhood, with slowly worsening weakness and thinning (wasting) of the muscles in the feet, legs, and later the hands. Problems with balance, walking, and feeling (sensation) are common. CMT2S is caused by changes in a gene called IGHMBP2, and is usually passed down in an autosomal recessive pattern, which means both parents carry a silent copy of the gene. uniprot.org+3NCBI+3

CMT2S usually starts in childhood. Children often develop weakness and thinning of the muscles in the feet and lower legs first. Later, weakness can move to the hands and arms. Feeling in the feet and hands can become reduced. Reflexes (like the ankle jerk) are often weak or absent. The disease usually gets worse very slowly over many years. NCBI+1

CMT2S is caused by harmful changes (mutations) in a single gene called IGHMBP2. These changes are present from birth and are passed in families in an autosomal recessive pattern. This means a person is affected when they receive one faulty copy of the gene from each parent. National Organization for Rare Disorders+1

Other names

CMT2S is known by several other medical names. These include “Charcot-Marie-Tooth disease, axonal, type 2S,” “Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2S,” “Charcot-Marie-Tooth neuropathy, type 2S,” and the short code “CMT2S.” All of these labels describe the same condition. NCBI+1

In some databases, CMT2S is listed under the OMIM number 616155 and the disease ID DOID:0110171. These codes help doctors and researchers recognize that they are talking about this specific genetic type of Charcot-Marie-Tooth disease that is linked to mutations in the IGHMBP2 gene. diseases.jensenlab.org+1

Types

Experts do not divide CMT2S into official “subtypes” the way they do for all the other forms of CMT (such as CMT1, CMT2A, CMTX). Instead, CMT2S is one small member of the larger CMT2 (axonal CMT) group. However, in the clinic, doctors may still talk about different patterns of CMT2S based on age at onset, severity, or extra features. Wikipedia+1

Typical childhood-onset CMT2S
This is the form most often described in reports. Symptoms begin in the first decade of life, with slowly progressive weakness and wasting of the distal (far) muscles in the legs and sometimes the hands. Feeling may be mildly reduced, and breathing is usually normal, unlike in SMARD1, another IGHMBP2 disease. NCBI+1
Early infant-onset CMT2S
Some children show signs in late infancy, such as delayed walking, clumsy gait, or foot deformities. These cases can be more severe at first and may be confused with other early-onset neuropathies. However, they still follow a slowly progressive course without the strong breathing problems seen in SMARD1. IJ Case Reports and Images+1
Later-childhood or adolescent-onset CMT2S
In a few reported cases, symptoms started later, for example around school age or early teenage years. The basic pattern is the same: distal weakness, reduced reflexes, and length-dependent sensory loss. The later the onset, the milder the disability often is, but this can vary from person to person. Muscular Dystrophy Association+1
IGHMBP2-related spectrum (CMT2S vs SMARD1)
CMT2S sits on a disease spectrum with spinal muscular atrophy with respiratory distress type 1 (SMARD1), which is also caused by IGHMBP2 mutations. In SMARD1, weakness and severe breathing problems start in infancy. In CMT2S, weakness and sensory loss develop more slowly in childhood and breathing is usually spared. The exact clinical picture depends on which IGHMBP2 mutations are present and on other background genes. Frontiers+1

Causes

In CMT2S, all “causes” are different ways that the IGHMBP2 gene or protein can be damaged or how it is inherited. They all lead to too little functional IGHMBP2 protein in motor and sensory neurons.

Autosomal recessive inheritance of IGHMBP2 mutations
The main cause of CMT2S is autosomal recessive inheritance. A child gets one faulty IGHMBP2 gene from each parent, who are usually healthy carriers. When both copies are faulty, the cells cannot make enough normal IGHMBP2 protein, and peripheral nerves slowly become damaged. cosylab.iiitd.edu.in+1
Missense mutations in IGHMBP2
A missense mutation changes one building block (amino acid) in the IGHMBP2 protein. Some missense variants reduce how well the protein can bind DNA or RNA or perform its helicase function. This “weak” protein cannot fully support neuron health and can lead to the CMT2S form of disease. Frontiers+1
Nonsense mutations in IGHMBP2
Nonsense mutations create a premature stop signal in the gene. This makes a short, incomplete protein that is usually broken down by the cell. In CMT2S, many patients carry one truncating (nonsense) mutation paired with another mutation, together lowering functional protein levels enough to cause axonal neuropathy. Frontiers+1
Frameshift mutations in IGHMBP2
Frameshift mutations add or remove small pieces of DNA so the reading frame of the gene shifts. This usually produces a long stretch of incorrect amino acids followed by an early stop. The resulting protein is unstable and non-functional, further decreasing IGHMBP2 activity in neurons. Frontiers+1
Splice-site mutations in IGHMBP2
Some mutations hit the splice sites, the signals that tell the cell how to cut and join gene segments. This can remove important exons or add wrong sequences, again leading to a faulty or missing protein. Splice errors can create a milder or more severe phenotype depending on how much normal transcript remains. PMC+1
Compound heterozygous mutations
Many people with CMT2S have two different IGHMBP2 mutations, one on each copy of the gene. This is called compound heterozygosity. Each mutation partly reduces protein function, and together they lower IGHMBP2 activity enough to cause CMT2S but not as severe as full loss seen in SMARD1. PMC+1
Homozygous mutations in IGHMBP2
In some families, the same IGHMBP2 mutation is inherited from both parents, often due to parental relatedness (consanguinity). Having two identical faulty copies can cause CMT2S with a more uniform clinical picture within the family. IJ Case Reports and Images+1
Mutations in the helicase domain of IGHMBP2
IGHMBP2 has helicase domains that help unwind nucleic acids during cellular processes. Mutations in certain helicase regions can disturb energy use and nucleic-acid handling. Specific domain changes are linked with whether a person develops SMARD1 or the milder CMT2S phenotype. Frontiers+1
Mutations in the C-terminal region (last exon)
Studies show that truncating mutations in the last exon of IGHMBP2 are especially associated with CMT2S. This region may be important for stabilizing the protein in axons. When it is lost, neurons survive but their long projections gradually degenerate, leading to axonal neuropathy. Frontiers+1
Partial loss-of-function of IGHMBP2
CMT2S usually results from partial loss of IGHMBP2 function, not complete absence. Enough protein remains to avoid early respiratory failure, but not enough to keep long peripheral axons healthy over a lifetime. This explains why symptoms start in childhood and progress slowly. MDPI+1
Disturbed RNA processing in motor and sensory neurons
IGHMBP2 is thought to help handle RNA and DNA in the cell nucleus and cytoplasm. When the protein is faulty, RNA processing and gene expression in motor and sensory neurons may be disturbed. Over time, this stress leads to axonal degeneration in length-dependent fashion, starting in the longest nerves. PMC+1
Axonal vulnerability due to high energy demand
Long axons in the legs and arms need constant energy and protein transport to stay healthy. When IGHMBP2 function is reduced, the cell’s ability to maintain these long axons is weakened, so they degenerate first. This is why symptoms start in the feet and hands in CMT2S. CMT Research Foundation+1
Secondary damage to Schwann cell support
Even though CMT2S is an axonal neuropathy, Schwann cells (the myelin-forming cells) rely on healthy axons for proper function. Axonal degeneration can cause secondary changes in Schwann cells and myelin. This contributes further to weakness and sensory loss over time. Wikipedia+1
Genetic background and modifier genes
Different people with similar IGHMBP2 mutations can have different severity. This suggests that other genes (modifier genes) may influence how strongly the main mutation shows itself. These background genes may affect pathways such as mitochondrial function, axonal transport, or myelin support. MDPI+1
Environmental stress on already fragile axons
While CMT2S is genetic, outside factors like repeated minor nerve injuries, poorly fitting shoes, or uncontrolled diabetes can further stress already fragile axons. This does not cause CMT2S by itself, but may worsen weakness and numbness in someone who already has IGHMBP2-related neuropathy. Cleveland Clinic+1
Consanguinity (parents being related)
In some reported families, parents are related (for example, cousins). This increases the chance that both parents carry the same rare IGHMBP2 mutation, so a child can inherit two faulty copies and develop CMT2S. IJ Case Reports and Images+1
New (de novo) IGHMBP2 mutations
Sometimes a pathogenic mutation arises for the first time in the egg or sperm, or early embryo, instead of being inherited from a known carrier parent. This “de novo” event can lead to CMT2S in a child even when there is no family history. Wiley Online Library+1
IGHMBP2 variants with milder biochemical effect
Some IGHMBP2 changes weaken, but do not completely destroy, the protein’s activity. People with these milder variants may develop CMT2S instead of SMARD1. The level of remaining protein activity appears to be a key cause of whether the disease is mainly neuropathy or also involves breathing muscles. MDPI+1
IGHMBP2 variants that alter protein stability
Certain missense variants change how the protein folds and how stable it is. Unstable IGHMBP2 can be quickly degraded inside the cell, reducing its amount even if the gene is still expressed. This protein instability is another cause of axonal dysfunction in CMT2S. ResearchGate+1
IGHMBP2-related disease spectrum mechanisms
Research shows that the same gene, IGHMBP2, can cause SMARD1 or CMT2S depending on the exact variants and how they affect different domains. The combination of variants and the person’s own genetic background causes the specific CMT2S phenotype, with slowly progressive axonal neuropathy and usually normal breathing. PMC+1

Symptoms

Distal muscle weakness in the legs
The most common symptom is weakness in the muscles around the ankles and feet. Children may trip, have difficulty running, or show foot drop. This happens because the longest motor axons are affected first and cannot carry strong signals from the spinal cord to the leg muscles. NCBI+1
Muscle wasting (atrophy) of lower legs
Over time, the muscles in the lower legs shrink and look thinner. This “inverted champagne bottle” shape happens because weak muscles lose volume. The nerve damage is slowly progressive, so muscle wasting also develops slowly, often over many years. orpha.net+1
Foot deformities (pes cavus, hammertoes)
Many people with CMT2S develop high arches (pes cavus) and curled toes (hammertoes). These deformities form because some muscles in the feet are weaker than others, pulling the bones into abnormal positions. Once fixed, the deformities may make walking and shoe fitting harder. Wikipedia+1
Difficulty walking and running
Weakness and foot deformities lead to problems with walking. People may have a high-stepping gait, stumble easily, or need more effort to run. Later, some may need braces or other aids. The walking problem is often one of the first reasons families seek medical help. Cleveland Clinic+1
Reduced or absent ankle reflexes
On examination, doctors often find that ankle reflexes are very weak or absent. This is because the sensory and motor nerve fibers that form the reflex arc are damaged. Loss of reflexes is a simple, early sign of peripheral neuropathy in CMT2S. NCBI+1
Distal sensory loss (numbness, reduced feeling)
People may notice numbness, tingling, or a feeling like wearing socks or gloves even when they are not. Sensation to vibration, pinprick, temperature, and joint position can all be reduced, especially in the feet, because sensory axons are also damaged. NCBI+1
Hand weakness and fine motor problems
Later in the course, weakness can spread to the hands. Tasks that need fine finger control, such as buttoning clothes or writing, may become harder. Visible thinning of the small hand muscles may be seen, reflecting axonal loss in the nerves to the hands. ScienceDirect+1
Balance problems and unsteady gait
Loss of joint position sense and weakness in the ankles can make balance difficult, especially in the dark or on uneven ground. People may sway when standing with feet together or fall more easily when tired. This balance trouble reflects combined motor and sensory impairment. PM&R KnowledgeNow+1
Neuropathic pain or discomfort
Many people with CMT have aching, burning, or shooting pains in the feet or lower legs. In CMT2S, pain may be mild or moderate but can still affect sleep and daily life. It comes from irritated, damaged nerve fibers sending abnormal signals to the brain. Cleveland Clinic+1
Muscle cramps and fatigue
Weak and partly denervated muscles can cramp or twitch, especially after activity. Because walking takes more effort, people with CMT2S often feel muscle fatigue or tiredness in the legs after short distances compared with healthy people. PM&R KnowledgeNow+1
Hand and foot stiffness or contractures
Over time, tightness of tendons and muscles can cause the fingers or toes to stay in bent positions (contractures). This stiffness limits movement and may further reduce function, even if the underlying muscle has some strength left. PM&R KnowledgeNow+1
Mild scoliosis or spinal posture changes
Some people with CMT develop mild curvature of the spine (scoliosis) or other posture changes because of uneven muscle strength around the trunk. While not specific to CMT2S, this feature may accompany long-standing peripheral neuropathy. Wikipedia+1
Frequent sprains and ankle instability
Weak ankle muscles and poor sensation make the ankle joint unstable. People may repeatedly sprain their ankles or feel that the ankle “gives way.” This can lead to more pain, fear of walking, and further reduction in activity. Cleveland Clinic+1
Delayed motor milestones in children
Some children with CMT2S sit, stand, or walk later than their peers. Parents may notice that the child is clumsy, falls more often, or struggles to keep up with other children in running and sports. These early delays reflect underlying peripheral nerve dysfunction. PM&R KnowledgeNow+1
Slow overall progression without early respiratory failure
A key symptom pattern is slow progression over years, with mainly limb weakness and sensory loss and usually no early breathing problems. This distinguishes CMT2S from SMARD1, where respiratory distress appears in infancy. Frontiers+1

Diagnostic tests

Doctors use a combination of clinical examination, nerve tests, lab tests, imaging, and especially genetic testing to diagnose CMT2S and separate it from other neuropathies.

Physical examination tests

Full neurological examination
The doctor checks muscle strength, tone, reflexes, and sensation throughout the body. In CMT2S, they often find distal weakness, reduced ankle reflexes, and length-dependent sensory loss, with normal or near-normal strength close to the trunk. This pattern suggests a chronic, length-dependent peripheral neuropathy. NCBI+1
Gait observation and functional walking tests
The clinician watches how the person walks, runs, and turns. A high-stepping gait, foot drop, difficulty walking on heels, and trouble running point toward distal weakness. These observations help decide which further tests are needed. Muscular Dystrophy Association+1
Inspection of feet and hands
The doctor looks for high arches, hammertoes, clawing of toes, and wasting of the small muscles of the feet and hands. Such deformities support a chronic neuropathy like CMT and help distinguish it from sudden or acquired nerve disorders. Wikipedia+1
Reflex testing with a tendon hammer
Reflexes at the ankles and knees are checked. In CMT2S, ankle reflexes are typically reduced or absent, while knee reflexes may be reduced later. This loss of distal reflexes is common in axonal CMT and is an important clinical clue. NCBI+1
Sensory bedside examination
The examiner uses tools such as a tuning fork (vibration), cotton wisp (light touch), pin (pain), and cold metal (temperature) to test feeling. In CMT2S, the person often has reduced vibration and pinprick sensation in the feet first, then the hands, showing a length-dependent pattern. NCBI+1

Manual (bedside functional) tests

Manual muscle testing (MRC grading)
The doctor tests strength of individual muscle groups (for example ankle dorsiflexion, toe extension, hand grip) by pushing against them. Each group is scored from 0 to 5. In CMT2S, distal muscles are weaker than proximal ones, and this pattern can be tracked over time. PM&R KnowledgeNow+1
Romberg test for balance
The person stands with feet together, first with eyes open, then closed. If they sway much more with eyes closed, this suggests sensory ataxia from loss of joint position sense in the feet, which can occur in length-dependent neuropathy like CMT2. PM&R KnowledgeNow+1
Heel-toe walking and tandem gait
Asking the person to walk on heels, on toes, and in a straight line placing one foot directly in front of the other tests distal strength and coordination. Difficulty with heel walking suggests weakness of muscles that lift the foot, a common feature in CMT2S. Muscular Dystrophy Association+1
Grip strength and hand function tests
Simple tasks such as squeezing the examiner’s fingers, opening jars, or manipulating small objects (buttons, coins) show fine motor ability. Wasting and weakness of hand muscles in advanced CMT2S can lower grip strength and slow these tasks. PM&R KnowledgeNow+1
Functional timed tests (for example, timed up-and-go)
Timed tests like standing from a chair, walking a set distance, and turning are sometimes used in clinics or research to measure how quickly someone can move. In CMT2S, times may gradually increase as weakness and balance problems progress. JAMA Network+1

Laboratory and pathological tests

Targeted genetic testing of IGHMBP2
The key laboratory test for CMT2S is DNA analysis of the IGHMBP2 gene. Sequencing looks for missense, nonsense, frameshift, or splice-site mutations. Finding two pathogenic variants (one on each gene copy) confirms the diagnosis of IGHMBP2-related CMT2S. PMC+1
Next-generation sequencing (NGS) neuropathy panels
Many centers use large NGS panels that test dozens of CMT genes at once, including IGHMBP2. This is useful when the clinical picture suggests CMT but the exact subtype is unknown. Identifying IGHMBP2 variants in this setting can reveal unexpected CMT2S cases. NCBI+1
Whole-exome or whole-genome sequencing
If panel testing is negative or unclear, broader methods like whole-exome or whole-genome sequencing may be used. These approaches can detect rare IGHMBP2 mutations or complex changes that standard tests might miss. They are often used in research and complex diagnostic work-ups. Wikipedia+1
Blood tests to rule out acquired neuropathies
Routine blood tests (such as blood sugar, vitamin B12, thyroid function, kidney and liver tests) help rule out treatable acquired causes of neuropathy. In pure CMT2S, these tests are usually normal. Their main role is to ensure that the neuropathy is hereditary rather than acquired. Cleveland Clinic+1
Nerve biopsy (rarely needed)
A small piece of a sensory nerve (for example sural nerve) can be removed and studied under a microscope. In CMT2, biopsies often show loss of large myelinated axons and clusters of regenerating fibers. Today, because genetic tests are so good, nerve biopsy is used much less often. cmtausa.org+1

Electrodiagnostic tests

Nerve conduction studies (NCS)
NCS measure how well electrical signals travel through the nerves. In CMT2S, amplitudes of sensory and motor responses are reduced (showing axonal loss), while conduction velocities are normal or only mildly slowed, consistent with axonal neuropathy rather than demyelinating CMT1. cmtausa.org+1
Electromyography (EMG)
A thin needle electrode is inserted into muscles to record electrical activity. EMG in CMT2S often shows chronic denervation and re-innervation patterns, such as large motor unit potentials and reduced recruitment, indicating long-standing axonal loss in motor nerves. ScienceDirect+1
Repetitive nerve stimulation or special EMG protocols
While CMT2S is not a neuromuscular junction disease, repetitive nerve stimulation or fatigue testing may be used in some centers to rule out other conditions. Normal neuromuscular transmission with abnormal axonal findings supports a diagnosis of hereditary axonal neuropathy. PM&R KnowledgeNow+1

Imaging tests

MRI of spine and brain (to exclude other causes)
MRI scans of the spine and brain are usually normal in CMT2S, but they can help rule out other problems such as spinal cord compression or central nervous system disease. A normal MRI with clear peripheral neuropathy signs points more strongly to a peripheral, hereditary cause. PM&R KnowledgeNow+1
Muscle MRI or ultrasound of muscles and nerves
Imaging of muscles can show patterns of fatty replacement and atrophy in distal muscles that fit with hereditary neuropathy. High-resolution ultrasound can show thinning of nerves. These techniques are mainly supportive but can help document disease distribution and severity. PM&R KnowledgeNow+1

Non-pharmacological treatments

Physiotherapy (physical therapy)
Physiotherapy is one of the most important treatments for CMT2S. A physiotherapist teaches safe exercises to keep muscles strong, joints flexible, and walking smoother. Sessions can include stretching, gentle resistance exercises, and practice with balance and coordination. Over time, regular therapy helps slow stiffness and contractures, reduces falls, and keeps you active in school and daily life. Physiopedia+2Muscular Dystrophy Association+2
Occupational therapy
Occupational therapists focus on daily activities such as writing, using a phone, dressing, and self-care. They can teach energy-saving tricks, recommend special grips or pens, and show easier ways to do tasks when hands or feet are weak. The goal is to keep you independent and confident, even if your strength and sensation are not normal. Muscular Dystrophy Association
Ankle-foot orthoses (AFOs)
AFOs are light braces worn inside shoes. They hold the ankle and foot in a good position to reduce foot drop, stop tripping, and improve walking speed and safety. They also help limit ankle twisting and fatigue. A good AFO should feel like part of your body, not a heavy cage, and is custom-made by an orthotist for your specific weakness and foot shape. Charcot-Marie-Tooth Association+1
Custom footwear and insoles
People with CMT2S often have high-arched or very flat feet. Special shoes and insoles support the arch, spread pressure more evenly, and prevent painful calluses and skin breakdown. Good footwear can also improve balance and reduce the risk of ankle sprains and falls, which are common when nerves and muscles are weak. Charcot-Marie-Tooth Association+1
Stretching and contracture prevention
Daily stretching of the calves, hamstrings, and foot muscles helps prevent the joints from becoming permanently stiff, which is called a contracture. Contractures make walking much harder and can increase pain. A physiotherapist usually designs a short home program that you can safely do every day to keep your ankles, knees, and hands moving well. Physiopedia+1
Strength training (low-impact)
Gentle, supervised strength exercises help keep the muscles that still work as strong as possible. Light resistance bands, body-weight exercises, or water-based strengthening can be used. The key is slow and careful training to avoid over-fatigue, because extremely hard exercise may stress already fragile axons. The therapist adjusts intensity based on your response. Physiopedia+1
Balance and gait training
CMT2S often causes unsteady walking because of weak ankle muscles and poor sensation. Therapists can train you to use visual cues, wide-base walking, and specific foot placement patterns. They may practice walking on different surfaces and turning safely. This reduces falls and builds confidence in crowded places like school corridors or streets. Physiopedia+1
Aquatic (water) therapy
Water supports body weight and makes movement easier. Aquatic therapy lets you practice walking, kicking, and balance with less risk of falling. The resistance of water also gently strengthens muscles. Many people with CMT find that exercising in a warm pool feels safer and more comfortable than land-based workouts. nhs.uk+1
Respiratory and posture exercises
Some people with CMT, especially if they develop spine curvature or chest muscle weakness, may have mild breathing problems. Breathing exercises, posture training, and sometimes simple devices to help expand the lungs can keep respiratory muscles working better and reduce tiredness, especially during infections. PMC
Pain psychology and coping skills
Chronic nerve pain can be exhausting and scary. Talking with a psychologist familiar with chronic illness can help you use relaxation, distraction, and cognitive-behavioral strategies to manage pain and worry. Learning these skills early may reduce how much medication you need later and improve sleep and mood. PMC
Hand splints and adaptive devices
If hand weakness makes it hard to grip pens, toothbrushes, or cutlery, hand splints and adapted tools can help. Splints support joints in a safe position and improve function. Things like built-up handles, zipper pulls, and Velcro fasteners reduce frustration and make school and self-care easier. Muscular Dystrophy Association
Fall-prevention home modifications
Simple changes at home, like removing loose rugs, adding grab bars in the bathroom, using non-slip mats, and improving lighting, reduce falls. An occupational therapist can visit and suggest specific changes so that moving around the house is safer, even when balance is poor. nhs.uk
Regular orthopedic follow-up
Orthopedic doctors check for foot deformities, scoliosis, and joint problems as you grow. Early spotting of problems allows timely braces, splints, or surgery if needed. This can prevent severe deformities that would be much harder to correct in adulthood. PMC+1
Vocational and school support
For teens, school and future work are major concerns. Vocational counselors and school support staff can help with extra time for tests, ergonomic desks, keyboard use instead of handwriting, and advice on careers that are less physically demanding but still match your interests.
Patient and family education
Understanding what CMT2S is—and what it is not—reduces unnecessary fear. Education covers genetics, symptoms, realistic expectations, and safe activity levels. It helps families support the teen without being over-protective and encourages long-term planning for independence. Muscular Dystrophy Association+1
Support groups and peer networks
Meeting others with CMT through patient organizations or online groups can reduce loneliness and provide practical tips. Hearing how older patients manage college, work, and relationships can be very encouraging and helps families see possible positive futures. Charcot-Marie-Tooth Association+1
Energy conservation training
Because weak muscles tire easily, therapists may teach you to plan your day so that heavy activities are spaced out, rest breaks are built in, and you use mobility aids when walking long distances. This prevents “overdoing it” and reduces next-day pain and fatigue.
Healthy weight and general fitness plan
Extra body weight makes walking harder and increases joint pain. A dietitian can suggest a balanced, nutrient-dense eating plan and safe activity levels so you stay as fit as possible without extreme dieting or exhausting exercise.
Orthotic review as disease progresses
Because CMT2S can slowly worsen, braces and splints need review and adjustment. Regular appointments with the orthotist make sure devices still fit well and actually help instead of rubbing or hurting. Updating orthotics at the right time can delay the need for surgery. Charcot-Marie-Tooth Association+1
Genetic counseling for family planning (for adults later)
When you are older, genetic counseling can explain how CMT2S is inherited, what testing is available, and what options exist if you want children in the future. This helps families make informed choices and prepares relatives who may also carry the gene. Monarch Initiative+1

Drug treatments

Important: These medicines are used to manage symptoms like neuropathic pain, muscle stiffness, mood, or sleep. None are proven to cure CMT2S itself. Exact drug choice and dose must be decided by a doctor who knows your full medical history. The FDA labels cited are for their approved uses (such as diabetic nerve pain), not specifically for CMT2S. PMC+3FDA Access Data+3FDA Access Data+3

Pregabalin
Drug class: Anticonvulsant / neuropathic pain agent.
Use: Helps nerve pain, burning, and shooting sensations.
Mechanism: Binds to calcium channels in nerve cells and reduces release of pain-related chemicals. FDA-approved for several neuropathic pain conditions. FDA Access Data+2FDA Access Data+2
Dose and timing: Usually taken 2–3 times per day; the exact dose depends on kidney function, age, and other medicines, and must be set by a doctor.
Side effects: Sleepiness, dizziness, weight gain, swelling, blurred vision, and sometimes mood changes.
Gabapentin
Drug class: Anticonvulsant / neuropathic pain agent.
Use: Widely used for chronic nerve pain.
Mechanism: Similar to pregabalin, it modulates calcium channels and reduces pain signal transmission.
Dose and timing: Typically taken in divided doses during the day; the doctor starts low and slowly increases.
Side effects: Drowsiness, dizziness, unsteady walking, and sometimes weight gain or mood changes.
Duloxetine
Drug class: Serotonin-norepinephrine reuptake inhibitor (SNRI).
Use: Treats neuropathic pain and also depression or anxiety, which may occur with long-term disability. FDA-approved for several pain conditions, including diabetic nerve pain and fibromyalgia. FDA Access Data+2FDA Access Data+2
Mechanism: Increases serotonin and norepinephrine in the brain and spinal cord to reduce pain signaling and improve mood.
Side effects: Nausea, dry mouth, sweating, increased blood pressure, and in young people a warning about suicidal thoughts.
Amitriptyline
Drug class: Tricyclic antidepressant.
Use: Low doses are often used at night to reduce nerve pain and help with sleep.
Mechanism: Blocks reuptake of serotonin and norepinephrine and modulates pain pathways.
Side effects: Dry mouth, constipation, weight gain, drowsiness, and sometimes heart rhythm changes, so heart history must be checked.
Nortriptyline
Drug class: Tricyclic antidepressant.
Use: Similar to amitriptyline but sometimes better tolerated.
Mechanism: Increases certain neurotransmitters and calms pain pathways.
Side effects: Dry mouth, constipation, dizziness, and possible heart effects; doses must be carefully adjusted, especially in teens.
Topical lidocaine (patch or cream)
Drug class: Local anesthetic.
Use: For local areas of burning or stabbing pain, especially on the feet.
Mechanism: Blocks sodium channels in the skin nerves to stop pain signals.
Side effects: Usually mild skin irritation; less chance of body-wide side effects because it acts mainly on the area where it is applied.
Topical capsaicin (cream or patch)
Drug class: TRPV1 agonist / local analgesic.
Use: Can reduce small-fiber nerve pain in some people.
Mechanism: Temporarily over-activates pain receptors and then makes them less responsive.
Side effects: Burning feeling on the skin at first; must be applied carefully and hands washed afterwards.
Non-steroidal anti-inflammatory drugs (NSAIDs)
Examples: Ibuprofen, naproxen.
Use: Help with joint or muscle aches but usually not very strong for pure neuropathic pain.
Mechanism: Block enzymes (COX) that make prostaglandins, which cause pain and inflammation.
Side effects: Stomach upset, kidney strain, and increased bleeding risk if used often or at high doses.
Tramadol (with great caution)
Drug class: Weak opioid / SNRI-like agent.
Use: Sometimes used for severe pain when other options fail, but usually avoided long-term, especially in teens.
Mechanism: Acts on opioid receptors and serotonin/norepinephrine systems.
Side effects: Nausea, dizziness, constipation, dependence, and seizure risk at higher doses.
Acetaminophen (paracetamol)
Drug class: Analgesic, not an NSAID.
Use: Mild pain or fever; sometimes combined with other agents for extra relief.
Mechanism: Acts in the central nervous system to reduce pain perception.
Side effects: Generally safe at correct doses, but overdose can severely damage the liver.
Baclofen
Drug class: Muscle relaxant / antispastic agent.
Use: Helps with muscle stiffness or spasms that can appear in some neuropathies.
Mechanism: Activates GABA-B receptors in the spinal cord, reducing muscle tone.
Side effects: Sleepiness, weakness, dizziness; doses must be increased and decreased slowly.
Tizanidine
Drug class: Alpha-2 adrenergic agonist muscle relaxant.
Use: Alternative for muscle spasm control.
Mechanism: Lowers excitatory signals in the spinal cord to relax muscles.
Side effects: Drowsiness, dry mouth, low blood pressure, and sometimes liver test changes.
Sertraline or similar SSRI (for mood)
Drug class: SSRI antidepressant.
Use: Treats depression and anxiety that may come with chronic illness.
Mechanism: Increases serotonin levels in the brain to stabilize mood.
Side effects: Nausea, sleep change, sexual side effects in adults, and a warning for suicidal thoughts in young people.
Melatonin (often counted as a supplement)
Drug class: Sleep-regulating hormone.
Use: Helps improve sleep quality when pain or worry interrupts rest.
Mechanism: Mimics the natural sleep hormone made by the brain.
Side effects: Usually mild, such as morning grogginess or vivid dreams.
Vitamin D (when low)
Drug class: Vitamin, sometimes used as medicine.
Use: Corrects vitamin D deficiency, supports bone and muscle health, and may reduce fracture risk in people with weak balance.
Side effects: High doses for too long can cause high calcium levels; blood tests guide safe dosing.
B-complex vitamins (especially B1, B6, B12 – in safe doses)
Drug class: Vitamins.
Use: Support general nerve health when there is deficiency.
Mechanism: These vitamins are co-factors in energy production and nerve function.
Side effects: Very high B6 doses over time can actually damage nerves, so a doctor must set the dose.
Alpha-lipoic acid (sometimes prescribed as a “drug” in some countries)
Drug class: Antioxidant.
Use: Used in some neuropathic conditions to reduce oxidative stress.
Mechanism: Helps recycle other antioxidants and may protect nerve cells from damage caused by free radicals.
Side effects: Nausea, skin rash, or low blood sugar in rare cases.
Simple analgesic combinations (doctor-chosen)
Sometimes doctors combine low doses of different pain medicines (for example, acetaminophen with an NSAID or a neuropathic pain drug) to get better pain control while keeping each dose smaller. This must always be managed by a clinician to avoid overdose or dangerous interactions.
Medications for associated conditions (e.g., anti-arrhythmics, if needed)
If CMT2S co-exists with other health problems, doctors may prescribe additional medicines (for example, for heart rhythm or blood pressure). These are not for CMT itself but are important for overall safety.
Medicines used in clinical trials (experimental)
New drugs, such as gene-targeted therapies or small molecules aimed at nerve protection, are being studied in CMT in research settings. Participation is strictly controlled and monitored, often in specialist centers. PMC+1

Dietary molecular supplements

Again, always check with a doctor before taking supplements, especially if you already use medicines.

Omega-3 fatty acids (fish oil or algae oil)
Omega-3s support general nerve membrane health and reduce inflammation. They may help joint stiffness and overall cardiovascular health. Typical doses are split during the day with meals, but exact amounts depend on age and other conditions. Possible side effects include mild stomach upset or fishy aftertaste and, at high doses, slightly increased bleeding tendency.
Alpha-lipoic acid
As an antioxidant, alpha-lipoic acid may protect nerves from oxidative damage. Studies in diabetic neuropathy show some symptom improvement, but strong data in CMT2S are limited. It is usually taken once or twice daily. Side effects include nausea or skin rash in some people, and it may lower blood sugar, especially if combined with diabetes medicines.
Acetyl-L-carnitine
This supplement helps mitochondria (cell “power plants”) produce energy. It may support nerve regeneration and reduce fatigue. It is often taken in divided doses. Some people notice mild stomach upset or restlessness. Evidence in inherited neuropathies is still emerging.
Coenzyme Q10
CoQ10 is another mitochondrial helper molecule involved in energy production. It may support muscle endurance and general vitality. It is typically taken with food to improve absorption. Side effects are usually mild, such as stomach discomfort or headache.
Vitamin D
If blood tests show low vitamin D, supplements support bone strength and muscle function, which is especially important if walking is unsteady and falls are a risk. Dosing and monitoring must be set by a clinician to avoid vitamin D overdose.
Vitamin B12
B12 is vital for myelin and axonal health. If a deficiency is present, replacing B12 can improve nerve function and prevent further damage. It can be taken by mouth or injection, depending on the cause of deficiency. It is generally very safe under medical guidance.
Folate (vitamin B9)
Folate works closely with B12 in DNA and myelin production. When low, it can worsen nerve and blood problems. A doctor may add folate if tests show deficiency. Side effects are rare at normal doses but very high doses can mask B12 deficiency.
Magnesium
Magnesium supports muscle relaxation and nerve function. It may help with cramps and general muscle comfort. Too much can cause diarrhea or, in very high doses with kidney disease, more serious problems, so dosing must be cautious.
Vitamin C
Vitamin C is an antioxidant and supports collagen in skin and blood vessels. Adequate levels help wound healing, which is important when feet are at risk for blisters and sores from altered walking. Large doses can cause stomach upset or kidney stones in susceptible people.
Vitamin E
Vitamin E is another fat-soluble antioxidant that protects cell membranes, including nerve membranes, from oxidative damage. Supplements should be given only under guidance because high doses can increase bleeding risk and interact with blood-thinning drugs.

Immune-booster / regenerative / stem-cell-related drugs

For CMT2S, no stem cell or gene therapy is yet approved in routine clinical practice. Research is ongoing, mostly in animal models and early human trials for different CMT types or related conditions. PMC+1

Gene-replacement therapy (experimental)
Researchers are studying viral vectors (like AAV) that deliver a healthy copy of the faulty gene to nerve cells. For IGHMBP2-related disease, early studies are mainly in animals and related conditions. These therapies aim to restore normal protein function and slow or stop nerve damage, but they are available only in clinical trials and have unknown long-term risks.
Mesenchymal stem cell infusions (experimental)
Some studies explore using stem cells from bone marrow or fat tissue to release growth factors that might protect nerves and reduce inflammation. Evidence is still very limited, and there is a risk of unregulated clinics offering unsafe treatments. These approaches should only be considered inside properly controlled research programs.
Neurotrophic factor-based treatments
Scientists are testing drugs or biologic agents that mimic natural nerve growth factors. The idea is to support axon survival and encourage regrowth. These are experimental and not specific to CMT2S yet, but could become important in the future.
Immunomodulatory drugs in special cases
CMT2S itself is genetic, not autoimmune. However, if a person with CMT also has a separate immune disease attacking nerves, doctors may use steroids, IVIG, or other immunosuppressants. These medicines calm the immune system and may protect nerves in that separate condition, but they do not correct the IGHMBP2 mutation.
High-dose vitamin therapies under supervision
Some centers explore higher-dose combinations of vitamins and antioxidants to support nerve health. Because very high doses can be harmful (especially B6, vitamin D, and E), this must be carefully designed and monitored by specialists and is not a simple “immune booster.”
Future combined gene and cell therapies
Researchers are considering combinations of gene editing (for example, CRISPR-based tools) and stem cell strategies to repair or replace damaged neurons. These ideas are still mostly in the laboratory and early animal studies, but they show how future treatment for CMT2S might become more regenerative rather than only supportive. PMC+1

Surgeries

Foot deformity correction (osteotomy)
If the foot arch becomes very high or the foot turns inward, bone-cutting operations (osteotomies) can realign the foot. The surgeon reshapes or repositions bones so that weight is spread more evenly. This can reduce pain, make shoe fitting easier, and improve walking safety. Recovery takes time and includes physiotherapy. PMC+1
Tendon transfer for foot drop
In tendon transfer surgery, a stronger tendon is moved to help lift the foot during walking. This can reduce tripping and allow lighter braces or, in some cases, no braces at all. It is usually considered when weakness is stable but severe and conservative measures no longer work well.
Ankle or foot joint fusion
If joints are very unstable or painful, surgeons may fuse them so they no longer move. This can give a more solid base for standing and reduce pain, but also reduces flexibility. It is chosen only when other options are not enough and after careful discussion.
Spinal surgery for scoliosis
In some people, muscle imbalance can lead to curvature of the spine. When the curve is large or progressing, spinal fusion surgery may be recommended to prevent worsening, protect lung function, and reduce pain. This is major surgery and is done in specialized centers.
Hand surgery and nerve decompression
If hand weakness and deformity or nerve compression (for example carpal tunnel) limit function badly, a hand surgeon may release tight structures or reposition tendons. The goal is to improve grip and fine motor tasks like writing or buttoning clothes.

Prevention and lifestyle

You cannot prevent having the CMT2S gene, but you can reduce complications and disability:

Stay physically active within safe limits (regular walking, stretching, and supervised exercise).
Avoid extreme or high-impact sports that risk ankle injuries or falls.
Wear supportive shoes and AFOs as recommended to prevent deformities and sprains.
Check feet daily for blisters, cuts, or pressure spots, especially if sensation is reduced.
Keep a healthy weight to lower strain on weak muscles and joints.
Do not smoke; smoking reduces blood flow to nerves and slows healing.
Avoid or use great caution with medicines known to be toxic to nerves (for example some chemotherapy drugs), always under specialist advice.
Get recommended vaccinations (like flu shots) to reduce severe infections that could worsen weakness.
Protect your home environment from fall hazards (good lighting, no loose rugs, sturdy railings).
Keep regular appointments with your neurologist and therapy team so problems are caught early. Muscular Dystrophy Association+2PMC+2

What to eat and what to avoid

Eat: Plenty of fruits and vegetables in many colors to supply vitamins, minerals, and antioxidants that support general health and tissue repair.
Eat: Lean proteins such as fish, eggs, beans, and poultry to maintain muscle mass and aid recovery after exercise.
Eat: Whole grains (brown rice, oats, whole-wheat bread) for steady energy and fiber.
Eat: Healthy fats from nuts, seeds, olive oil, and fatty fish to support nerve membranes and the heart.
Eat: Enough calcium-rich foods (milk, yogurt, fortified plant milks) to support strong bones, especially if walking is limited.
Avoid: Regular large amounts of sugary drinks and sweets, which can promote weight gain and blood sugar problems.
Avoid: Heavy, greasy fast food that adds calories without much nutrition and can worsen fatigue.
Avoid: Very high doses of any vitamin or supplement without blood tests and medical supervision, because some can harm nerves or organs.
Avoid: Excess caffeine and energy drinks late in the day, which can worsen sleep when you already struggle with pain.
Avoid: Alcohol, which can damage nerves further and interact with many pain medicines (also usually not legal or safe for teens).

When to see a doctor

You should be in regular follow-up with a neurologist, but seek medical help sooner if:

You notice a sudden change in weakness, walking, or balance (for example, rapid new foot drop or frequent falls).
Pain becomes strong enough that you cannot sleep or go to school normally.
You develop new symptoms such as shortness of breath, trouble swallowing, or severe back pain.
You see ulcers, deep blisters, or infections on your feet or legs.
You feel very low in mood, hopeless, or have thoughts of hurting yourself — tell a trusted adult and doctor immediately so they can support you.
Any medicine or supplement seems to cause strong side effects like severe dizziness, rash, breathing difficulty, or heart-related symptoms.

FAQs

Is Charcot-Marie-Tooth disease axonal type 2S curable?
No. There is currently no cure that removes the IGHMBP2 mutation or completely restores damaged axons. Treatment focuses on managing symptoms, preventing complications, and keeping you as active and independent as possible. PMC+1
Does everyone with CMT2S end up in a wheelchair?
Not necessarily. Severity varies widely. Many people have lifelong walking difficulties but stay mobile with braces, physiotherapy, and possibly surgery. Some may need a wheelchair for long distances or later in life, while others use it only during flares of fatigue. Orpha+1
When do symptoms usually start?
Symptoms often begin in the first decade of life with clumsiness, frequent ankle sprains, or difficulty running. Over time, foot deformities and hand weakness may appear. NCBI+1
Can exercise make CMT2S worse?
Reasonable, well-planned exercise supervised by a physiotherapist is usually helpful and does not damage nerves. Very intense, unplanned over-training, especially with heavy weights, may cause excessive fatigue and strain, so balance is important. Physiopedia+1
Will orthoses or braces weaken my muscles?
Braces support weak muscles and improve safety; they do not directly cause muscle wasting. In fact, by preventing falls and abnormal foot positions, they may help you stay active and protect joints in the long term. Charcot-Marie-Tooth Association+1
Are there special medicines just for CMT2S?
At the moment, no medicine is approved specifically to treat CMT2S. Doctors use drugs that help with nerve pain, stiffness, and mood based on evidence from other neuropathies and chronic pain conditions. Research into targeted treatments is ongoing. PMC+1
Can diet alone fix my nerves?
Diet cannot repair the IGHMBP2 gene or completely reverse axon loss. However, a balanced, nutrient-dense diet supports general health, muscle strength, bone density, and immune defenses, which all matter when living with CMT2S.
Is CMT2S contagious?
No. It is a genetic condition and cannot be “caught” from another person. It is passed through families by inherited gene changes. Monarch Initiative+1
Will my children have CMT2S in the future?
Because CMT2S is usually autosomal recessive, both parents must carry the gene for a child to be affected. If you have CMT2S, your children will at least be carriers, and whether they are affected depends on your partner’s genes. Genetic counseling can provide personal risk estimates. Monarch Initiative+1
Why is my balance so poor even if I am not very weak?
CMT2S affects sensory fibers that tell your brain where your feet are in space. When this feedback is reduced, your body struggles to keep steady, especially in the dark or on uneven surfaces, even if muscles are not extremely weak. Muscular Dystrophy Association+1
Are stem cell clinics advertised online safe?
Most “stem cell cures” advertised on the internet for CMT are not proven and may be unsafe, expensive, or unethical. Any stem cell or gene therapy should be inside official research trials with clear oversight, not in commercial clinics claiming guaranteed cures. PMC
Can CMT2S affect breathing?
It mainly affects limb nerves, but in some people, muscle weakness, spine changes, or very advanced disease may slightly affect breathing or cough strength. Regular check-ups help detect this early so respiratory support or exercises can be planned if needed. PMC
What shoes are best for CMT2S?
Supportive shoes with a firm heel counter, wide toe box, and space for AFOs or insoles work best. Avoid high heels, very flexible soles, or loose slip-ons because they increase the risk of falls and ankle sprains. Charcot-Marie-Tooth Association+1
Can I play sports?
Many people with CMT2S enjoy low-impact sports like swimming, cycling, or carefully supervised gym work. Contact sports or activities that require quick direction changes or jumping may be risky. A physiotherapist or sports doctor can help you choose suitable activities. Physiopedia+1
What is the most important thing I can do right now?
The most important steps are: stay in regular contact with a neurologist, follow physiotherapy and orthotic advice, protect your feet and joints, keep a healthy lifestyle, and speak openly about pain or mood changes. Early, steady care often makes a big difference in long-term quality of life. Muscular Dystrophy Association+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 22, 2025.

PDF Documents For This Disease Condition

References

SaveSavedRemoved 0